AB Science (France) Investor Sentiment

AB Stock  EUR 0.79  0.01  1.25%   
About 61% of AB Science's investor base is looking to short. The analysis of current outlook of investing in AB Science SA suggests that many traders are alarmed regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
  
over two months ago at news.google.com         
AB Science announces a slight delay in the publication of its 2024 half-year financial report - Yaho...
Google News at Macroaxis
over two months ago at news.google.com         
AB Science provides an update on the microtubule program AB89 and in particular the ability of AB89 ...
Google News at Macroaxis
over two months ago at news.google.com         
AB Science provides an update on the development of masitinib in progressive forms of multiple scler...
Google News at Macroaxis
over three months ago at news.google.com         
Allstate Sets New 12-Month High on Analyst Upgrade - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Integral Ad Science Holding Corp. CFO Sells 44,179.52 in Stock - American Banking and Market News
Google News at Macroaxis
over three months ago at news.google.com         
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19 - Yahoo ...
Google News at Macroaxis
over three months ago at news.google.com         
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimers drug - Reuters
Google News at Macroaxis
over three months ago at news.google.com         
EMA takes negative view on masitinib Ocaliva, Translarna out - BioWorld Online
Google News at Macroaxis
over three months ago at news.google.com         
Air Canada Short Interest Up 20.1 percent in June - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
MicroSectors U.S. Big Oil Index 3x Leveraged ETN Shares Gap Up to 492.88 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Park Avenue Securities LLC Sells 1825 Shares of iShares Russell 2000 Value ETF - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
AB Science EPAAB investor three-year losses grow to 85 percent as the stock sheds 8.3m this past wee...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the ...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science reports its revenues for the year 2023 and provides an update on its activities - GlobeNe...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocyt...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AB Science that are available to investors today. That information is available publicly through AB Science media outlets and privately through word of mouth or via AB Science internal channels. However, regardless of the origin, that massive amount of AB Science data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AB Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AB Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AB Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AB Science alpha.

AB Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for AB Science Stock analysis

When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance